IMF Videos Search Content For Healthcare Provider (392) Healthcare Professional (389) Care Partner (333) Patient (328) Series - Any - About the IMF (2) ASCO/EHA (163) ASH (230) Ask Dr. Durie (238) Black Swan Research Initiative (7) Community Workshops (33) Emerging Therapies (20) Facebook Live (21) Health Equity (16) IMF History (4) IMWG (13) Inspirational (16) Living Well with Myeloma (34) Myeloma in a Minute (19) Myeloma Made Simple (15) Myeloma University (12) NLB Webcasts (1) Patient & Family Webinar (27) Q&A (19) Recent News and Developments (4) Treatments (4) Trending Searches in Myeloma (1) Topics Clinical Trials (365) Financial Considerations (18) Frontline Therapy (163) Health Equity (40) Inspirational Stories (24) Insurance (5) Lab & Imaging Tests (78) Lifestyle (53) Mental & Emotional Health (31) Myeloma 101 (75) Myeloma in the News (6) Public Policy & Advocacy (20) Q&A's (40) Recorded Seminars & Workshops (47) Recorded Webinars (27) Relapse/Refractory Myeloma (283) Research Updates (345) Symptom Management (158) Myeloma Stage Early Relapse (1–3 Lines of Therapy) (211) High-Risk Myeloma (153) High-risk Smoldering Myeloma (90) Late Relapse (4–6 Lines of Therapy) (271) MGUS (78) Newly Diagnosed (Pre-Treatment or First Treatment) (246) Smoldering Myeloma (116) Types of Therapy Immunomodulatory drugs (IMiDs) (183) Immunotherapies (CAR T; BiTE, etc.) (250) Monoclonal antibodies (157) Proteasome inhibitors (140) Stem cell transplant (141) Steroids (92) Supportive Care (192) Year Published 2026 (35) 2025 (109) 2024 (102) 2023 (115) 2022 (111) 2021 (126) 2020 (81) 2019 (76) 2018 (55) 2017 (37) 2016 (26) 2015 (36) Trusted Voices Dr. Brian GM Durie (214) Dr. Joseph Mikhael (107) Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO (28) Dr. María-Victoria Mateos (13) Dr. Saad Usmani (11) Dr. Shaji Kumar (6) Donna Catamero, ANP-BC, OCN, CCRC (5) Dr. Sagar Lonial (5) Dr. Rafat Abonour (4) Dr. Sigurður Kristinsson (4) Dr. Urvi A. Shah (4) Dr. Tom Martin (3) Dr. Philippe Moreau (1) Dr. S. Vincent Rajkumar (1) Heather Cooper Ortner (1) Sort Newest firstOldest firstA -> ZZ -> ARelevance Subcutaneous vs IV isatuximab + pomalidomide/dexamethasone in R/R MM: IRAKLIA phase 3 study July 21, 2025 ASCO/EHA Updated results from iMMagine-1: Phase 2 study of anitocabtagene autoleucel for relapsed/refractory multiple myeloma July 18, 2025 ASCO/EHA Isatuximab-Carfilzomib-Lenalidomide-Dexamethasone in NDMM: MRD Negativity Rates and Safety July 17, 2025 ASCO/EHA Long-term Outcomes of Cilta-cel in Relapsed/Refractory Multiple Myeloma July 17, 2025 ASCO/EHA Top 10 Myeloma Breakthroughs from ASCO & EHA: Frontline Therapy, Early & Late Relapse, and CAR T-cell Insights July 17, 2025 Emerging Therapies Multiple Myeloma Q&A: Why Diagnosis Can Take 12+ Months, MGUS, Costs & FDA News July 10, 2025 Q&A Myeloma University | Bispecifics in Multiple Myeloma July 7, 2025 Myeloma University Palliative Care in Multiple Myeloma: What It Really Means for Patients and Families July 3, 2025 Myeloma in a Minute Top Myeloma Research Presented at ASCO, EHA & IMWG 2025 Webinar: The Patient Perspective July 1, 2025 ASCO/EHA Elranatamab in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: MagnetisMM-6 June 27, 2025 ASCO/EHA Talquetamab Side Effects: Managing Taste Loss, Hair & Nail Changes in Myeloma June 26, 2025 Myeloma Made Simple CAR-T Therapy in RR AL Amyloidosis: NEXICART-2 Trial Safety and Efficacy June 23, 2025 ASCO/EHA Load More
